Home/Filings/4/0001213900-25-092540
4//SEC Filing

Qian LinLin 4

Accession 0001213900-25-092540

CIK 0002019505other

Filed

Sep 25, 8:00 PM ET

Accepted

Sep 26, 7:19 PM ET

Size

5.7 KB

Accession

0001213900-25-092540

Insider Transaction Report

Form 4
Period: 2025-09-24
Qian LinLin
DirectorChief Financial Officer10% Owner
Transactions
  • Award

    Class A Common Stock

    2025-09-24+80,0008,128,555 total
Footnotes (2)
  • [F1]Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. One third (1/3) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date a letter of intent or memorandum of understanding is signed in connection with an initiative being developed by the Company (the "Initiative"), one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date the Initiative enters proof-of-concept or beta launch, and, the remaining one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date of full commercial launch of the Initiative.
  • [F2]Includes 130,495 shares of restricted stock and 7,998,060 shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Documents

1 file

Issuer

Health In Tech, Inc.

CIK 0002019505

Entity typeother

Related Parties

1
  • filerCIK 0001849454

Filing Metadata

Form type
4
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 7:19 PM ET
Size
5.7 KB